Alnylam Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
CEOYvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees2,230
Employees2,230
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2002
Founded2002
Employees2,230
Employees2,230
ALNY Key Statistics
Market cap52.54B
Market cap52.54B
Price-Earnings ratio1.65K
Price-Earnings ratio1.65K
Dividend yield—
Dividend yield—
Average volume1.99M
Average volume1.99M
High today$402.44
High today$402.44
Low today$397.25
Low today$397.25
Open price$397.25
Open price$397.25
Volume768.80K
Volume768.80K
52 Week high$495.55
52 Week high$495.55
52 Week low$205.87
52 Week low$205.87
Stock Snapshot
With a market cap of 52.54B, Alnylam Pharmaceuticals(ALNY) trades at $397.65. The stock has a price-to-earnings ratio of 1652.45.
As of 2026-01-01, Alnylam Pharmaceuticals(ALNY) stock has fluctuated between $397.25 and $402.44. The current price stands at $397.65, placing the stock +0.1% above today's low and -1.2% off the high.
The Alnylam Pharmaceuticals(ALNY)'s current trading volume is 768.8K, compared to an average daily volume of 1.99M.
During the past year, Alnylam Pharmaceuticals(ALNY) stock moved between $205.87 at its lowest and $495.55 at its peak.
During the past year, Alnylam Pharmaceuticals(ALNY) stock moved between $205.87 at its lowest and $495.55 at its peak.
Analyst ratings
68%
of 31 ratingsBuy
67.7%
Hold
29%
Sell
3.2%
People also own
Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.